Breast Cancer HIV Drugs May Face Tougher Part D Climate Under Protected Class Proposal

Breast Cancer, HIV Drugs May Face Tougher Part D Climate Under Protected Class Proposal

13:41 EST 27 Nov 2018 | SCRIP

Medicare proposed rule exposes Part D protected class drugs to threat of formulary exclusion if price increases exceed a certain...

More From BioPortfolio on "Breast Cancer, HIV Drugs May Face Tougher Part D Climate Under Protected Class Proposal"